Femke Bouwman

DR.

20082019
If you made any changes in Pure these will be visible here soon.

Research Output 2008 2019

Filter
Review article
2018

Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia

For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, Boccardi, M., Festari, C., Altomare, D., Gandolfo, F., Orini, S., Nobili, F., Frisoni, G. B., Agosta, F., Arbizu, J., Bouwman, F., Drzezga, A., Nestor, P. & Walker, Z., 1 Jul 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1470-1486 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1557-1566

Research output: Contribution to journalReview articleAcademicpeer-review

Clinical utility of FDG-PET for the clinical diagnosis in MCI

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1497-1508

Research output: Contribution to journalReview articleAcademicpeer-review

Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia

EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1534-1545

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease

EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 9, p. 1487-1496

Research output: Contribution to journalReview articleAcademicpeer-review

Disclosure of amyloid positron emission tomography results to individuals without dementia: a systematic review

de Wilde, A., van Buchem, M. M., Otten, R. H. J., Bouwman, F., Stephens, A., Barkhof, F., Scheltens, P. & van der Flier, W. M., 28 Jul 2018, In : Alzheimer's Research & Therapy. 10, 1, p. 72

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders, 2018, In : European Journal of Neurology. 25, 10, p. 1201-1217

Research output: Contribution to journalReview articleAcademicpeer-review